Search

Your search keyword '"Xia, Ningshao"' showing total 1,649 results
Start Over Author "Xia, Ningshao"
1,649 results on '"Xia, Ningshao"'

5. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects

Author

Fu, Rao, Qi, Ruoyao, Xiong, Hualong, Lei, Xing, Jiang, Yao, He, Jinhang, Chen, Feng, Zhang, Liang, Qiu, Dekui, Chen, Yiyi, Nie, Meifeng, Guo, Xueran, Zhu, Yuhe, Zhang, Jinlei, Yue, Mingxi, Cao, Jiali, Wang, Guosong, Que, Yuqiong, Fang, Mujing, Wang, Yingbin, Chen, Yixin, Cheng, Tong, Ge, Shengxiang, Zhang, Jun, Yuan, Quan, Zhang, Tianying, and Xia, Ningshao

Published
2024
Full Text
View/download PDF

9. Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies.

Author

Wei, Feixue, Goodman, Marc T, Xia, Ningshao, Zhang, Jun, Giuliano, Anna R, D'Souza, Gypsyamber, Hessol, Nancy A, Schim van der Loeff, Maarten F, Dai, Jianghong, Neukam, Karin, de Pokomandy, Alexandra, Poynten, I Mary, Geskus, Ronald B, Burgos, Joaquin, Etienney, Isabelle, Moscicki, Anna-Barbara, Donà, Maria Gabriella, Gillison, Maura L, Nyitray, Alan G, Nowak, Rebecca G, Yunihastuti, Evy, Zou, Huachun, Hidalgo-Tenorio, Carmen, Phanuphak, Nittaya, Molina, Jean-Michel, Schofield, Alice M, Kerr, Stephen, Fan, Song, Lu, Yong, Ong, Jason J, Chikandiwa, Admire T, Teeraananchai, Sirinya, Squillace, Nicola, Wiley, Dorothy J, Palefsky, Joel M, Georges, Damien, Alberts, Catharina J, and Clifford, Gary M

Subjects
Cancer, Infectious Diseases, Behavioral and Social Science, Sexually Transmitted Infections, Clinical Research, Sexual and Gender Minorities (SGM/LGBT*), Prevention, HIV/AIDS, Aetiology, 2.2 Factors relating to the physical environment, Infection, Good Health and Well Being, Male, Humans, Female, Homosexuality, Male, Human Papillomavirus Viruses, Papillomavirus Infections, HIV Infections, Incidence, Sexual and Gender Minorities, Sexual Behavior, Anal Canal, Anus Diseases, Longitudinal Studies, Anus Neoplasms, Human papillomavirus 16, HIV, Papillomaviridae, HPV, anus, incidence, clearance, Biological Sciences, Medical and Health Sciences, Microbiology
Abstract

BackgroundUnderstanding the natural history of anal high-risk human papillomavirus (hrHPV) infection is key for designing anal cancer prevention programs but has not been systematically characterized.MethodsWe reanalyzed data from 34 studies including 16 164 individuals in 6 risk groups defined by human immunodeficiency virus (HIV) status, sex, and male sexuality: men who have sex with men (MSM) and people with HIV (MSMWH), HIV-negative MSM, women with HIV (WWH), HIV-negative women, men who have sex with women (MSW) with HIV (MSWWH), and HIV-negative MSW. We used Markov models to estimate incidence and clearance of 13 hrHPV types and their determinants.ResultsHuman papillomavirus (HPV) 16 had the highest incidence-clearance ratio of the hrHPV types. MSMWH had the highest hrHPV incidence (eg, 15.5% newly HPV-16 infected within 2 years), followed by HIV-negative MSM (7.5%), WWH (6.6%), HIV-negative women (2.9%), MSWWH (1.7%), and HIV-negative MSW (0.7%). Determinants of HPV-16 incidence included HIV status and number of sexual partners for MSM, women, and MSW, and anal sex behavior for MSM only. HPV-16 clearance was lower for people with HIV (PWH) and lower for prevalent than incident infection. Among MSM, increasing age was associated with lower clearance of prevalent, but not incident, HPV-16 infection.ConclusionsThis robust and unifying analysis of anal hrHPV natural history is essential to designing and predicting the impact of HPV vaccination and HPV-based screening programs on anal cancer prevention, particularly in MSM and PWH. Importantly, it demonstrates the higher carcinogenic potential of longstanding anal prevalent hrHPV infection than more recent incident infection.

Published
2023

10. Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies.

Author

Wei, Feixue, Xia, Ningshao, Ocampo, Rebeca, Goodman, Marc T, Hessol, Nancy A, Grinsztejn, Beatriz, Ortiz, Ana P, Zhao, Fanghui, Kojic, Erna M, Kaul, Rupert, Heard, Isabelle, Morhason-Bello, Imran O, Moscicki, Anna-Barbara, de Pokomandy, Alexandra, Palefsky, Joel M, Rodrigues, Luana LS, Dube Mandishora, Racheal S, Ramautarsing, Reshmie A, Franceschi, Silvia, Godbole, Sheela V, Tso, Fernanda K, Menezes, Lynette J, Lin, Chunqing, and Clifford, Gary M

Subjects
Cervix Uteri, Humans, Papillomaviridae, HIV, Papillomavirus Infections, HIV Infections, Anus Neoplasms, Prevalence, Age Factors, Adolescent, Adult, Anal Canal, Uterine Cervical Neoplasms, Female, Human papillomavirus 16, Early Detection of Cancer, Young Adult, Squamous Intraepithelial Lesions, Human Papillomavirus Viruses, HPV, anus, cervix, women, Cancer, Prevention, Sexually Transmitted Infections, Infectious Diseases, HIV/AIDS, Cervical Cancer, Aetiology, 2.2 Factors relating to the physical environment, Infection, Good Health and Well Being, Biological Sciences, Medical and Health Sciences, Microbiology
Abstract

BackgroundAge-specific data on anal, and corresponding cervical, human papillomavirus (HPV) infection are needed to inform female anal cancer prevention.MethodsWe centrally reanalyzed individual-level data from 26 studies reporting HPV prevalence in paired anal and cervical samples by human immunodeficiency virus (HIV) status and age. For women with HIV (WWH) with anal high-grade squamous intraepithelial lesions or worse (HSIL+), we also investigated concurrent cervical cytopathology.ResultsIn HIV-negative women, HPV16 prevalence decreased significantly with age, both at anus (4.3% at 15-24 years to 1.0% at ≥55 years; ptrend = 0.0026) and cervix (7.4% to 1.7%; ptrend < 0.0001). In WWH, HPV16 prevalence decreased with age at cervix (18.3% to 7.2%; ptrend = 0.0035) but not anus (11.5% to 13.9%; ptrend = 0.5412). Given anal HPV16 positivity, concurrent cervical HPV16 positivity also decreased with age, both in HIV-negative women (ptrend = 0.0005) and WWH (ptrend = 0.0166). Among 48 WWH with HPV16-positive anal HSIL+, 27 (56%) were cervical high-risk HPV-positive, including 8 with cervical HPV16, and 5 were cervical HSIL+.ConclusionsAge-specific shifts in HPV16 prevalence from cervix to anus suggest that HPV infections in the anus persist longer, or occur later in life, than in the cervix, particularly in WWH. This is an important consideration when assessing the utility of cervical screening results to stratify anal cancer risk.

Published
2023

17. Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Author

Qi, Ruoyao, Fu, Rao, Lei, Xing, He, Jinhang, Jiang, Yao, Zhang, Liang, Wu, Yangtao, Wang, Siling, Guo, Xueran, Chen, Feng, Nie, Meifeng, Yang, Man, Chen, Yiyi, Zeng, Jing, Xu, Jingjing, Xiong, Hualong, Fang, Mujin, Que, Yuqiong, Yao, Youliang, Wang, Yingbin, Cao, Jiali, Ye, Huiming, Zhang, Yali, Zheng, Zizheng, Cheng, Tong, Zhang, Jun, Lin, Xu, Yuan, Quan, Zhang, Tianying, and Xia, Ningshao

Published
2024
Full Text
View/download PDF

23. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Author

Zhang, Liang, Jiang, Yao, He, Jinhang, Chen, Junyu, Qi, Ruoyao, Yuan, Lunzhi, Shao, Tiange, Zhao, Hui, Chen, Congjie, Chen, Yaode, Wang, Xijing, Lei, Xing, Gao, Qingxiang, Zhuang, Chunlan, Zhou, Ming, Ma, Jian, Liu, Wei, Yang, Man, Fu, Rao, Wu, Yangtao, Chen, Feng, Xiong, Hualong, Nie, Meifeng, Chen, Yiyi, Wu, Kun, Fang, Mujin, Wang, Yingbin, Zheng, Zizheng, Huang, Shoujie, Ge, Shengxiang, Cheng, Shih Chin, Zhu, Huachen, Cheng, Tong, Yuan, Quan, Wu, Ting, Zhang, Jun, Chen, Yixin, Zhang, Tianying, Li, Changgui, Qi, Hai, Guan, Yi, and Xia, Ningshao

Published
2023
Full Text
View/download PDF

27. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Huang, Shoujie, Zhang, Xuefeng, Su, Yingying, Zhuang, Chunlan, Tang, Zimin, Huang, Xingcheng, Chen, Qi, Zhu, Kongxin, Hu, Xiaowen, Ying, Dong, Liu, Xiaohui, Jiang, Hanmin, Zang, Xia, Wang, Zhongze, Yang, Changlin, Liu, Donglin, Wang, Yijun, Tang, Quan, Shen, Wentong, Cao, Huanhuan, Pan, Huirong, Ge, Shengxiang, Huang, Yue, Wu, Ting, Zheng, Zizheng, Zhu, Fengcai, Zhang, Jun, and Xia, Ningshao

Published
2024
Full Text
View/download PDF

31. Prophylactic Hepatitis E Vaccine

Author

Zhang, Jun, Zheng, Zizheng, Xia, Ningshao, Crusio, Wim E., Series Editor, Dong, Haidong, Series Editor, Radeke, Heinfried H., Series Editor, Rezaei, Nima, Series Editor, Steinlein, Ortrud, Series Editor, Xiao, Junjie, Series Editor, and Wang, Youchun, editor

Published
2023
Full Text
View/download PDF

32. Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants.

Author

Li, Tingting, Xue, Wenhui, Zheng, Qingbing, Song, Shuo, Yang, Chuanlai, Xiong, Hualong, Zhang, Sibo, Hong, Minqing, Zhang, Yali, Yu, Hai, Zhang, Yuyun, Sun, Hui, Huang, Yang, Deng, Tingting, Chi, Xin, Li, Jinjin, Wang, Shaojuan, Zhou, Lizhi, Chen, Tingting, Wang, Yingbin, Cheng, Tong, Zhang, Tianying, Yuan, Quan, Zhao, Qinjian, Zhang, Jun, McLellan, Jason S, Zhou, Z Hong, Zhang, Zheng, Li, Shaowei, Gu, Ying, and Xia, Ningshao

Subjects
CHO Cells, Vero Cells, Animals, Humans, Cricetulus, Mice, Receptors, Virus, Antibodies, Monoclonal, Antibodies, Viral, Epitopes, Neutralization Tests, Immunization, Passive, Binding Sites, Protein Multimerization, HEK293 Cells, Pandemics, Sf9 Cells, Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus, Broadly Neutralizing Antibodies, Chlorocebus aethiops, COVID-19, SARS-CoV-2, Prevention, Vaccine Related, Emerging Infectious Diseases, Pneumonia & Influenza, Biotechnology, Pneumonia, Infectious Diseases, Lung, Immunization, Biodefense, Infection
Abstract

The emergence of numerous variants of SARS-CoV-2, the causative agent of COVID-19, has presented new challenges to the global efforts to control the COVID-19 pandemic. Here, we obtain two cross-neutralizing antibodies (7D6 and 6D6) that target Sarbecoviruses' receptor-binding domain (RBD) with sub-picomolar affinities and potently neutralize authentic SARS-CoV-2. Crystal structures show that both antibodies bind a cryptic site different from that recognized by existing antibodies and highly conserved across Sarbecovirus isolates. Binding of these two antibodies to the RBD clashes with the adjacent N-terminal domain and disrupts the viral spike. Both antibodies confer good resistance to mutations in the currently circulating SARS-CoV-2 variants. Thus, our results have direct relevance to public health as options for passive antibody therapeutics and even active prophylactics. They can also inform the design of pan-sarbecovirus vaccines.

Published
2021

34. Micronanoparticled risedronate exhibits potent vaccine adjuvant effects

Author

Nie, Meifeng, Wu, Shuyu, Chen, Yiyi, Wu, Yangtao, Chen, Ruitong, Liu, Yue, Yue, Mingxi, Jiang, Yao, Qiu, Dekui, Yang, Man, Wang, Zikang, Gao, Jiahua, Xiong, Hualong, Qi, Ruoyao, He, Jinhang, Zhang, Jinlei, Zhang, Liang, Wang, Yingbin, Fang, Mujin, Que, Yuqiong, Yao, Youliang, Li, Shaowei, Zhang, Jun, Zhao, Qinjian, Yuan, Quan, Zhang, Tianying, and Xia, Ningshao

Published
2024
Full Text
View/download PDF

39. Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Author

Zhu, Fengcai, Huang, Shoujie, Liu, Xiaohui, Chen, Qi, Zhuang, Chunlan, Zhao, Hui, Han, Jinle, Jaen, Anjuli May, Do, Thai Hung, Peter, Jonathan Grant, Dorado, Alexander Gonzalez, Tirador, Louie S, Zabat, Gelza Mae A, Villalobos, Ralph Elvi M, Gueco, Gemalyn Pineda, Botha, Lauren Livia Greta, Iglesias Pertuz, Shirley Patricia, Tan, Jiaxiang, Zhu, Kongxin, Quan, Jiali, Lin, Hongyan, Huang, Yue, Jia, Jizong, Chu, Xiafei, Chen, Junyu, Chen, Yixin, Zhang, Tianying, Su, Yingying, Li, Changgui, Ye, Xiangzhong, Wu, Ting, Zhang, Jun, and Xia, Ningshao

Published
2023
Full Text
View/download PDF

40. Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection

Author

Hong, Junping, Zhong, Ling, Liu, Liqin, Wu, Qian, Zhang, Wanlin, Chen, Kaiyun, Wei, Dongmei, Sun, Hui, Zhou, Xiang, Zhang, Xinyu, Kang, Yin-Feng, Huang, Yang, Chen, Junyu, Wang, Guosong, Zhou, Yan, Chen, Yanhong, Feng, Qi-Sheng, Yu, Hai, Li, Shaowei, Zeng, Mu-Sheng, Zeng, Yi-Xin, Xu, Miao, Zheng, Qingbing, Chen, Yixin, Zhang, Xiao, and Xia, Ningshao

Published
2023
Full Text
View/download PDF

41. Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

Author

Xu, Longfa, Zheng, Qingbing, Zhu, Rui, Yin, Zhichao, Yu, Hai, Lin, Yu, Wu, Yuanyuan, He, Maozhou, Huang, Yang, Jiang, Yichao, Sun, Hui, Zha, Zhenghui, Yang, Hongwei, Huang, Qiongzi, Zhang, Dongqing, Chen, Zhenqin, Ye, Xiangzhong, Han, Jinle, Yang, Lisheng, Liu, Che, Que, Yuqiong, Fang, Mujin, Gu, Ying, Zhang, Jun, Luo, Wenxin, Zhou, Z Hong, Li, Shaowei, Cheng, Tong, and Xia, Ningshao

Subjects
Biomedical and Clinical Sciences, Immunology, Biotechnology, Infectious Diseases, 2.1 Biological and endogenous factors, Aetiology, 2.2 Factors relating to the physical environment, Infection, Animals, Antibodies, Neutralizing, Capsid, Capsid Proteins, Cryoelectron Microscopy, Enterovirus, Enterovirus B, Human, Enterovirus Infections, Female, Mice, Mice, Inbred BALB C, Models, Molecular, Protein Interaction Domains and Motifs, Receptors, Virus, Virion, Virus Uncoating, coxsackievirus, coxsackievirus and adenovirus receptor, cryoEM structures, neutralizing antibody, virus uncoating, Microbiology, Medical Microbiology, Biochemistry and cell biology, Medical microbiology
Abstract

Enterovirus uncoating receptors bind at the surface depression ("canyon") that encircles each capsid vertex causing the release of a host-derived lipid called "pocket factor" that is buried in a hydrophobic pocket formed by the major viral capsid protein, VP1. Coxsackievirus and adenovirus receptor (CAR) is a universal uncoating receptor of group B coxsackieviruses (CVB). Here, we present five high-resolution cryoEM structures of CVB representing different stages of virus infection. Structural comparisons show that the CAR penetrates deeper into the canyon than other uncoating receptors, leading to a cascade of events: collapse of the VP1 hydrophobic pocket, high-efficiency release of the pocket factor and viral uncoating and genome release under neutral pH, as compared with low pH. Furthermore, we identified a potent therapeutic antibody that can neutralize viral infection by interfering with virion-CAR interactions, destabilizing the capsid and inducing virion disruption. Together, these results define the structural basis of CVB cell entry and antibody neutralization.

Published
2021

44. Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

Author

Wang, Wei, Zheng, Qingbing, Pan, Dequan, Yu, Hai, Fu, Wenkun, Liu, Jian, He, Maozhou, Zhu, Rui, Cai, Yuze, Huang, Yang, Zha, Zhenghui, Chen, Zhenqin, Ye, Xiangzhong, Han, Jinle, Que, Yuqiong, Wu, Ting, Zhang, Jun, Li, Shaowei, Zhu, Hua, Zhou, Z Hong, Cheng, Tong, and Xia, Ningshao

Subjects
Biochemistry and Cell Biology, Biological Sciences, Infectious Diseases, Biotechnology, Aetiology, 2.2 Factors relating to the physical environment, Infection, Capsid, Capsid Proteins, Cryoelectron Microscopy, Herpesvirus 3, Human, Humans, Models, Molecular, Protein Domains, Varicella Zoster Virus Infection, Virion, Microbiology, Medical Microbiology
Abstract

Varicella-zoster virus (VZV) is a medically important human herpesvirus that causes chickenpox and shingles, but its cell-associated nature has hindered structure studies. Here we report the cryo-electron microscopy structures of purified VZV A-capsid and C-capsid, as well as of the DNA-containing capsid inside the virion. Atomic models derived from these structures show that, despite enclosing a genome that is substantially smaller than those of other human herpesviruses, VZV has a similarly sized capsid, consisting of 955 major capsid protein (MCP), 900 small capsid protein (SCP), 640 triplex dimer (Tri2) and 320 triplex monomer (Tri1) subunits. The VZV capsid has high thermal stability, although with relatively fewer intra- and inter-capsid protein interactions and less stably associated tegument proteins compared with other human herpesviruses. Analysis with antibodies targeting the N and C termini of the VZV SCP indicates that the hexon-capping SCP-the largest among human herpesviruses-uses its N-terminal half to bridge hexon MCP subunits and possesses a C-terminal flexible half emanating from the inner rim of the upper hexon channel into the tegument layer. Correlation of these structural features and functional observations provide insights into VZV assembly and pathogenesis and should help efforts to engineer gene delivery and anticancer vectors based on the currently available VZV vaccine.

Published
2020

47. Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

Author

He, Maozhou, Xu, Longfa, Zheng, Qingbing, Zhu, Rui, Yin, Zhichao, Zha, Zhenghui, Lin, Yu, Yang, Lisheng, Huang, Yang, Ye, Xiangzhong, Li, Shuxuan, Hou, Wangheng, Wu, Yangtao, Han, Jinle, Liu, Dongxiao, Li, Zekai, Chen, Zhenqin, Yu, Hai, Que, Yuqiong, Wang, Yingbin, Yan, Xiaodong, Zhang, Jun, Gu, Ying, Zhou, Z Hong, Cheng, Tong, Li, Shaowei, and Xia, Ningshao

Subjects
Biomedical and Clinical Sciences, Immunology, Vaccine Related, Infectious Diseases, Biodefense, Prevention, Biotechnology, Immunization, Emerging Infectious Diseases, 2.1 Biological and endogenous factors, Aetiology, Good Health and Well Being, Animals, Antibodies, Neutralizing, Antibodies, Viral, Capsid Proteins, Cell Line, Cryoelectron Microscopy, Enterovirus, Enterovirus A, Human, Hand, Foot and Mouth Disease, Humans, Mice, Viral Vaccines, Virion, coxsackievirus A16, cryo-EM structure, therapeutic antibody, vaccine design, Microbiology, Medical Microbiology, Biochemistry and cell biology, Medical microbiology
Abstract

Hand, foot, and mouth disease is a common childhood illness primarily caused by coxsackievirus A16 (CVA16), for which there are no current vaccines or treatments. We identify three CVA16-specific neutralizing monoclonal antibodies (nAbs) with therapeutic potential: 18A7, 14B10, and NA9D7. We present atomic structures of these nAbs bound to all three viral particle forms-the mature virion, A-particle, and empty particle-and show that each Fab can simultaneously occupy the mature virion. Additionally, 14B10 or NA9D7 provide 100% protection against lethal CVA16 infection in a neonatal mouse model. 18A7 binds to a non-conserved epitope present in all three particles, whereas 14B10 and NA9D7 recognize broad protective epitopes but only bind the mature virion. NA9D7 targets an immunodominant site, which may overlap the receptor-binding site. These findings indicate that CVA16 vaccines should be based on mature virions and that these antibodies could be used to discriminate optimal virion-based immunogens.

Published
2020

48. Contributors

Author

Abzug, Mark J., primary, Acharya, Priyamvada, additional, Acosta, Anna M., additional, Ahmed, S. Sohail, additional, Amanna, Ian J., additional, Anderson, Annaliesa S., additional, Asturias, Edwin J., additional, Bachmann, Martin F., additional, Bahl, Sunil, additional, Bailey, Justin R., additional, Baker, Carol J., additional, Balfour, Henry H., additional, Baric, Ralph S., additional, Barnett, Elizabeth D., additional, Barrett, Alan D.T., additional, Belser, Jessica A., additional, Berzofsky, Jay A., additional, Bethony, Jeffrey M., additional, Brewer-Jensen, Paul D., additional, Bubak, Andrew N., additional, Burns, Cara C., additional, Caplan, Arthur L., additional, Cavaleri, Marco, additional, Chandran, Aruna, additional, Cherian, Thomas, additional, Clemens, John D., additional, Cochino, Emil, additional, Cohet, Catherine, additional, Cohn, Amanda, additional, Cortese, Margaret M., additional, Crowcroft, Natasha S., additional, Curtis, Nigel, additional, Damron, F. Heath, additional, Danchin, Margie, additional, Debbink, Kari, additional, Desai, Sachin N., additional, Davis, Emily H., additional, Decker, Michael D., additional, Denison, Mark R., additional, DeStefano, Frank, additional, Douglas, R. Gordon, additional, Dreher-Lesnick, Sheila M., additional, Eberhardt, Christiane S., additional, Edmunds, W. John, additional, Edwards, Caitlin E., additional, Edwards, Kathryn M., additional, Eggers, Rudolf, additional, Ellis, Ronald, additional, Erdman, Dean D., additional, Ertl, Hildegund C.J., additional, Estivariz, Concepcion F., additional, Fine, Paul E.M., additional, Finn, Theresa M., additional, Fisher, Allison M., additional, Fitzwater, Sean Patrick, additional, Freedman, Mark S., additional, Friede, Martin, additional, Friedlander, Arthur M., additional, Frumento, Nicole, additional, Fry, Alicia M., additional, Garçon, Nathalie, additional, Geris, Jennifer M., additional, Gershon, Anne A., additional, Gervier, Regis, additional, Gessner, Bradford D., additional, Gilbert, Peter B., additional, Gomez, Phillip Louis, additional, Ginsberg, Ann M., additional, Grabenstein, John D., additional, Graham, Rachel L., additional, Graham, Barney S., additional, Granoff, Dan M., additional, Gray, Gregory C., additional, Greenberg, David P., additional, Grohskopf, Lisa A., additional, Gruber, Marion F., additional, Guerena, Fernando B., additional, Havelange, Nicolas, additional, Halstead, Scott B., additional, Hanekom, Willem A., additional, Harrison, Lee H., additional, Hawn, Thomas R., additional, Haynes, Barton F., additional, Healy, C. Mary, additional, Hills, Susan L., additional, Hirabayashi, Kuniko, additional, Holmgren, Jan, additional, Hombach, Joachim M., additional, Hotez, Peter Jay, additional, Howe, Barbara J., additional, Hunegnaw, Ruth, additional, Izopet, Jacques, additional, Jamieson, Denise J., additional, Jansen, Kathrin, additional, Jarrahian, Courtney, additional, Johansen, Kari, additional, Kahn, Geoffrey D., additional, Karron, Ruth A., additional, Katz, Jacqueline M., additional, Kennedy, Richard B., additional, Broojerdi, Alireza Khadem, additional, Khetsuriani, Nino, additional, Khudyakov, Yury, additional, Klugman, Keith P., additional, Kocher, Jacob F., additional, Kollaritsch, Herwig, additional, Kotloff, Karen L., additional, Kozarsky, Phyllis E., additional, Kreimer, Aimée R., additional, Kroger, Andrew T., additional, Kwong, Peter D., additional, Lal, Manjari, additional, Levin, Myron J., additional, Levine, Myron M., additional, Lindesmith, Lisa C., additional, Lindstrand, Ann, additional, Ljungman, Per, additional, Lowy, Douglas R., additional, Lundgren, Anna, additional, Lydon, Patrick, additional, Macklin, Grace R., additional, Maeng, Hoyoung M., additional, Mahalingam, Ravi, additional, Malley, Richard, additional, Mallory, Michael L., additional, Marfin, Anthony A., additional, Markowitz, Lauri E., additional, Marshall, CDR Valerie, additional, McCollum, Andrea, additional, Meyer, Sarah, additional, McNamara, Lucy A., additional, Menning, Lisa, additional, Messacar, Kevin, additional, Miller, Mark A., additional, Milutinovic, Pavle, additional, Modlin, John F., additional, Monath, Thomas P., additional, Morabito, Kaitlyn M., additional, Moss, William J., additional, Mulholland, Kim, additional, Mura, Manuela, additional, Musher, Daniel M., additional, Nagel, Maria A., additional, Nair, G. Balakrish, additional, Nelson, Noele P., additional, Netea, Mihai G., additional, Neuzil, Kathleen Maletic, additional, Niemeyer, Christy S., additional, Nohynek, Hanna, additional, Norheim, Gunnstein, additional, Nussbaum, Lauren, additional, O’Brien, Katherine L., additional, O’Leary, Sean, additional, Ockenhouse, Christian, additional, Offit, Paul A., additional, Okwo-Bele, Jean-Marie, additional, Olkhanud, Purevdorj B., additional, Omer, Saad B., additional, Orenstein, Walter A., additional, Oyston, Petra C.F., additional, Parashar, Umesh D., additional, Patel, Manish M., additional, Payne, Daniel C., additional, Pebody, Richard, additional, Pecetta, Simone, additional, Perlman, Stanley, additional, Pierson, Benjamin, additional, Pierson, Theodore C., additional, Pittet, Laure F., additional, Pittman, Phillip R., additional, Plotkin, Stanley A., additional, Plotkin, Susan L., additional, Poland, Gregory A., additional, Pollard, Sir Andrew John, additional, Poovorawan, Yong, additional, Proctor, Richard A., additional, Qadri, Firdausi, additional, Rao, Agam, additional, Rappuoli, Rino, additional, Reef, Susan E., additional, Rogalewicz, Joseph A., additional, Robinson, James Michael, additional, Roesel, Sigrun, additional, Rubin, Steven A., additional, Rupprecht, Charles E., additional, Rutter, Paul, additional, Samant, Vijay B., additional, Sambhara, Suryaprakash, additional, Samies, Nicole L., additional, Santosham, Mathuram, additional, Saunders, Kevin O., additional, Schiller, John T., additional, Schleiss, Mark R., additional, Schuerman, Lode, additional, Schwab, Jennifer, additional, Schwartz, Jason L., additional, Scobie, Heather M., additional, Scott, J. Anthony, additional, Shapiro, Eugene D., additional, Shenoy, Erica S., additional, Shimabukuro, Tom T., additional, Shouval, Daniel, additional, Siegrist, Claire-Anne, additional, Sitrin, Robert D., additional, Skinner, Nicole E., additional, Slifka, Mark K., additional, Sodha, Samir V., additional, Soeters, Heidi M., additional, Solomon, Tom, additional, Speiser, Daniel E., additional, Staples, J. Erin, additional, Steffen, Robert, additional, Stephens, David S., additional, Strebel, Peter M., additional, Subbarao, Kanta, additional, Sullivan, Nancy J., additional, Takashima, Yoshihiro, additional, Tate, Jacqueline E., additional, Tayman, Alice, additional, Telford, Sam R., additional, Thombley, Melisa, additional, Thomsen, Isaac, additional, Tohme, Rania A., additional, Trabold, Malin, additional, El-Turabi, Aadil, additional, Vaughn, David W., additional, Verardi, Raffaello, additional, Vicari, Andrea S., additional, Vidor, Emmanuel J., additional, Villafana, Tonya, additional, Vogt, Matthew R., additional, Walker, Mark J., additional, Walsh, Nick M., additional, Wanlapakorn, Nasamon, additional, Ward, John W., additional, Wassilak, Steven G.F., additional, Watts, Lisa A., additional, Weber, David J., additional, Weiner, David B., additional, Weng, Mark K., additional, Wexler, Deborah L., additional, Wharton, Melinda, additional, Whitley, Richard J., additional, Whitney, Cynthia G., additional, Wiehe, Kevin, additional, Williamson, E. Diane, additional, Wormser, Gary P., additional, Xia, Ningshao, additional, Yildirim, Inci, additional, Zehrung, Darin, additional, and Zweigart, Mark R., additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results